Literature DB >> 24224638

Pazopanib versus sunitinib in renal cancer.

Jochen Casper, Silke Schumann-Binarsch, Claus-Henning Köhne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24224638     DOI： 10.1056/NEJMc1311795

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

Review 1.  Bringing in health technology assessment and cost-effectiveness considerations at an early stage of drug development.

Authors:  Bengt Jönsson
Journal:  Mol Oncol       Date:  2014-10-23       Impact factor: 6.603

2.  68Ga-PSMA-11 PET/CT Parameter Correlates with Pathological VEGFR-2/PDGFR-β Expression in Renal Cell Carcinoma Patients.

Authors:  Jie Gao; Longxiyu Meng; Qinfeng Xu; Xiaozhi Zhao; Yongming Deng; Yao Fu; Suhan Guo; Kuiqiang He; Jiong Shi; Feng Wang; Shiwei Zhang; Hongqian Guo
Journal:  Mol Imaging Biol       Date:  2022-04-22       Impact factor: 3.484

Review 3.  Multidisciplinary management of clear-cell renal cell carcinoma in Africa and the Middle East: current practice and recommendations for improvement.

Authors:  Jamal Zekri; Lydia M Dreosti; Marwan Ghosn; Emad Hamada; Mohamed Jaloudi; Ola Khorshid; Blaha Larbaoui
Journal:  J Multidiscip Healthc       Date:  2015-07-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.